Side Effects Of Neuroendocrine Colon Cancer

One of the most aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The most negative part about the disease is that it is usually detected late into the advanced stages when it is extremely hard to curb it and treat it.

As the side effects of neuroendocrine colon cancer become visible only at very advanced stages, the rate of survival of the patient drops drastically Existing tumors are always malignant, and mostly detected with distant metastases. Surveys show reports tell us that in a great many cases of neuroendocrine cancer end with the death of the patient.

Although the possibilities of neuroendocrine carcinoma in colon are extremely unlikely, if unfortunately one is affected by this disease, the patient’s heath becomes much worse than patients who suffer from adenocarcinoma.

Research reveals that the final results of this cancer do not change with age, sex or tumor location. But neuroendocrine colon carcinoma does depend on the stage of the tumor. Normal trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. Though in several cases, if the tumor is in stage 3 or 4, it is a laborious and tough job to treat the neuroendocrine colon carcinoma.

It is unfortunate that medical science has very few methods to treat this kind of cancer. Among the more popular methods that doctors might use is immunohistochemical staining methods. a method which greatly helps the doctors to detect the critical nature of the neuroendocrine colon cancer and helps to determine the best medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumor with a monoclonal antibody A-80 which helps in identifying the quantum of neuroendocrine differentiation and nature of the damage caused to the health.

Neuroendocrine colon carcinoma is cumbersome to deal with and a case study in which several patients stuffered from this particular disease were examined, it was observed that a general rate of survival for this disease was approximately seven months. In a predominant stage these rates decrease, to as low as five months or less. Most of these cases were initially detected as carcinoids but later they developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery is not always a successful treatment so surgery may not provide the patient with a proper cure. Therefore it becomes necessary to notice the presence of this disease on time and provide proper medication for it.